143 results on '"Schaltz-Buchholzer, Frederik"'
Search Results
2. Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines
3. The association between BCG scars and self-reported chronic diseases: A cross-sectional observational study within an RCT of Danish health care workers
4. Using real-life data to model the impact of increasing BCG vaccination coverage and scar prevalence on all-cause infant mortality
5. Maternal Vaccination to Prevent Adverse Pregnancy Outcomes: An Underutilized Molecular Immunological Intervention?
6. Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?
7. Effects of neonatal BCG-Japan versus BCG-Russia vaccination on overall mortality and morbidity: randomized controlled trial from Guinea-Bissau (BCGSTRAIN II)
8. Non-Specific Effects of BCG in Portuguese Children under 5 years of age: Population Based Historical Birth Cohort Study (Preprint)
9. Non-Specific Effects of BCG in Portuguese Children under 5 years of age: Protocol for a Population Based Historical Birth Cohort Study (Preprint)
10. PA-753 Covid-19 in children: Immune response to SARS-CoV-2 infection in children under 5, Guinea-Bissau
11. PA-785 Characterization of anti-SARS-CoV-2 humoral immunity among health care workers in hospitals from the islands of Santiago and São Vicente, Cabo Verde
12. PA-734 BCG vaccine to reduce unplanned absenteeism due to illness of health care workers during the COVID-19 pandemic. A multi-center randomised controlled trial (BCG-COVID-RCT)
13. Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports
14. Using BCG Vaccine to Enhance Nonspecific Protection of Health Care Workers During the COVID-19 Pandemic: A Randomized Controlled Trial.
15. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: a randomized controlled trial
16. Early BCG-Denmark and Neonatal Mortality Among Infants Weighing
17. Prevalence of observed BCG scar in a cohort of health care workers from three Lusophone sub-Saharian African countries: cross-sectional comparative study
18. Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe.
19. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark
20. Erratum to ‘Maternal BCG primes for enhanced health benefits in the newborn’ [Journal of Infection Volume 84, Issue 3 (2022) 321-328]
21. A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions
22. Zika Virus IgG in Infants with Microcephaly, Guinea-Bissau, 2016
23. Mortality Risk Among Frail Neonates and Maternal BCG Vaccine Scar Status: Observational Study From Guinea-Bissau.
24. Mortality Risk Among Frail Neonates and Maternal BCG Vaccine Scar Status: Observational Study From Guinea-Bissau
25. Maternal BCG primes for enhanced health benefits in the newborn
26. Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial
27. The association between parental and neonatal BCG vaccination and neonatal T helper 17 cell expansion
28. The introduction of BCG vaccination to neonates in Northern Sweden, 1927–31: Re-analysis of historical data to understand the lower mortality among BCG-vaccinated children
29. Are BCG Skin Reactions the Most Important Correlates of BCG’s Specific and Non-Specific Effects?
30. Randomised Clinical Trials of COVID-19 Vaccines: Do Adenovirus-Vector Vaccines Have Beneficial Non-Specific Effects?
31. Using Large Cohort Data to Strengthen Information-Based Public Health Policies: An Appeal to Portuguese Authorities.
32. Neonatal Bacille Calmette-Guérin vaccination and tuberculin skin test reactions at 2- and 6-months: Effects on mortality up to 1 year of age
33. Neonatal Bacille Calmette-Guerin vaccination and tuberculin skin test reactions at 2-and 6-months: Effects on mortality up to 1 year of age
34. Parental Bacillus Calmette-Guerin vaccine scars decrease infant mortality in the first six weeks of life: A retrospective cohort study
35. Neonatal Bacille Calmette-Guérin vaccination and tuberculin skin test reactions at 2- and 6-months:Effects on mortality up to 1 year of age
36. Immediate Bacille Calmette-Guérin Vaccination to Neonates Requiring Perinatal Treatment at the Maternity Ward in Guinea-Bissau: A Randomized Controlled Trial
37. SARS-CoV2 sero-survey among adults involved in health care and health research in Guinea-Bissau, West Africa
38. BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau
39. BCG skin reactions by 2 months of age are associated with better survival in infancy:A prospective observational study from Guinea-Bissau
40. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic:A structured summary of a study protocol for a randomised controlled trial in Denmark
41. BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau
42. Feasibility of manual white blood cell counts as a predictor of neonatal sepsis in a low-resource setting
43. Early Vaccination With Bacille Calmette-Guérin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial
44. Are Bacille Calmette-Guérin Skin Reactions the Most Important Correlates of Bacille Calmette-Guérin's Specific and Nonspecific Effects?
45. Early Vaccination With Bacille Calmette-Guérin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial.
46. BCG vaccination–induced emergency granulopoiesis provides rapid protection from neonatal sepsis.
47. Early BCG Vaccination, Hospitalizations, and Hospital Deaths: Analysis of a Secondary Outcome in 3 Randomized Trials from Guinea-Bissau
48. Case Report: Iatrogenic Infection from Traditional Treatment of Stingray Envenomation
49. Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial
50. The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.